| scholarly article | Q13442814 |
| P2093 | author name string | Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene) | |
| P2860 | cites work | Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis | Q22252943 |
| Genetic association analysis of 13 nuclear-encoded mitochondrial candidate genes with type II diabetes mellitus: the DAMAGE study | Q24600599 | ||
| The expanding genetic overlap between multiple sclerosis and type I diabetes | Q24642348 | ||
| A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals | Q24644474 | ||
| Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering | Q24655574 | ||
| PLINK: a tool set for whole-genome association and population-based linkage analyses | Q24677407 | ||
| Vitamin D deficiency | Q27860616 | ||
| Haploview: analysis and visualization of LD and haplotype maps | Q27860955 | ||
| Principal components analysis corrects for stratification in genome-wide association studies | Q27860975 | ||
| 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation | Q28370605 | ||
| Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis | Q28943435 | ||
| Risk alleles for multiple sclerosis identified by a genomewide study | Q29614890 | ||
| New diagnostic criteria for multiple sclerosis: guidelines for research protocols | Q34271601 | ||
| Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis | Q34573482 | ||
| Successful treatment of animal models of rheumatoid arthritis with small-molecule cyclin-dependent kinase inhibitors | Q34738960 | ||
| 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis | Q35820661 | ||
| Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes | Q36803789 | ||
| Control of autoimmune diseases by the vitamin D endocrine system | Q37204961 | ||
| Common variants at CD40 and other loci confer risk of rheumatoid arthritis | Q37376871 | ||
| Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor | Q37435432 | ||
| CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis | Q37696199 | ||
| A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression. | Q38303947 | ||
| Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia | Q39136547 | ||
| The role of CD40 in the regulation of humoral and cell-mediated immunity | Q40393797 | ||
| CD40 signaling-mediated induction of Bcl-XL, Cdk4, and Cdk6. Implication of their cooperation in selective B cell growth | Q41259834 | ||
| Cyclin-dependent kinase 4 hyperactivity promotes autoreactivity in the immune system but protects pancreatic cell mass from autoimmune destruction in the nonobese diabetic mouse model. | Q42523353 | ||
| Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13. | Q43154311 | ||
| 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. | Q43775059 | ||
| 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis | Q44853183 | ||
| Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians | Q46466235 | ||
| Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. | Q51973496 | ||
| Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus | Q56591809 | ||
| MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT | Q68261496 | ||
| Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40 | Q72093299 | ||
| A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology | Q81441210 | ||
| T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients | Q82969711 | ||
| P4510 | describes a project that uses | genome-wide association study | Q1098876 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Australia | Q408 |
| multiple sclerosis | Q8277 | ||
| genome-wide association study | Q1098876 | ||
| data sharing | Q5227350 | ||
| susceptibility locus | Q62091149 | ||
| P304 | page(s) | 824-828 | |
| P577 | publication date | 2009-06-14 | |
| P1433 | published in | Nature Genetics | Q976454 |
| P1476 | title | Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. | |
| P478 | volume | 41 |
| Q52607615 | 1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis. |
| Q30630727 | A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis |
| Q89943881 | A New Risk Variant for Multiple Sclerosis at 11q23.3 Locus Is Associated with Expansion of CXCR5+ Circulating Regulatory T Cells |
| Q36798284 | A PheWAS approach in studying HLA-DRB1*1501. |
| Q57224488 | A Role for VAV1 in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis |
| Q52650349 | A Role for the Non-Receptor Tyrosine Kinase Abl2/Arg in Experimental Neuroinflammation. |
| Q35693931 | A common variant near TGFBR3 is associated with primary open angle glaucoma. |
| Q33675881 | A genome-wide association study identifies six novel risk loci for primary biliary cholangitis |
| Q47984633 | A genome-wide association study identifies three new risk loci for Kawasaki disease |
| Q28943404 | A genome-wide association study in progressive multiple sclerosis |
| Q34550781 | A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1). |
| Q34160962 | A non-synonymous SNP within membrane metalloendopeptidase-like 1 (MMEL1) is associated with multiple sclerosis |
| Q40991982 | A non-synonymous single-nucleotide polymorphism associated with multiple sclerosis risk affects the EVI5 interactome |
| Q33742905 | A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis. |
| Q28748710 | A polymorphism in the HLA-DPB1 gene is associated with susceptibility to multiple sclerosis |
| Q40722405 | A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis. |
| Q41738233 | A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis |
| Q38593055 | A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches. |
| Q35603685 | A systematic eQTL study of cis-trans epistasis in 210 HapMap individuals |
| Q33769952 | A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis |
| Q36438926 | Aggregation of multiple sclerosis genetic risk variants in multiple and single case families |
| Q43136367 | An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people |
| Q33603699 | An application of Random Forests to a genome-wide association dataset: methodological considerations & new findings |
| Q33651712 | An integrated approach to defining genetic and environmental determinants for major clinical outcomes involving vitamin D. |
| Q36059972 | An integrated approach to design novel therapeutic interventions for demyelinating disorders |
| Q37388834 | Analysis of CYP27B1 in multiple sclerosis |
| Q34283946 | Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis. |
| Q35231431 | Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel |
| Q34368609 | Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton. |
| Q27003330 | Association between Tumor Necrosis Factor- α-308 G/A Polymorphism and Multiple Sclerosis: A Systematic Review and Meta-Analysis |
| Q36774530 | Association between polymorphism of the vitamin D metabolism gene CYP27B1 and HLA-B27-associated uveitis. Is a state of relative immunodeficiency pathogenic in HLA B27-positive uveitis? |
| Q36302600 | Association between vitamin D receptor polymorphisms and multiple sclerosis: systematic review and meta-analysis of case-control studies |
| Q24273315 | Association claims in the sequencing era |
| Q88235115 | Association of CD40 Gene Polymorphisms with Susceptibility to Neuromyelitis Optica Spectrum Disorders |
| Q34979385 | Association of CD58 Polymorphism with Multiple Sclerosis and Response to Interferon ß Therapy in A Subset of Iranian Population |
| Q91642058 | Association of CD58 polymorphism and multiple sclerosis in Malaysia: a pilot study |
| Q37005355 | Association of EVI5 rs11808092, CD58 rs2300747, and CIITA rs3087456 polymorphisms with multiple sclerosis risk: A meta-analysis |
| Q34683951 | Association of SNPs of CD40 gene with multiple sclerosis in Russians |
| Q46554763 | Association of common variants in KIF21B and ankylosing spondylitis in a Chinese Han population: a replication study |
| Q35018315 | Association of multiple sclerosis susceptibility variants and early attack location in the CNS |
| Q33769709 | Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease |
| Q35875895 | Association study of four polymorphisms in the interleukin-7 receptor alpha gene with multiple sclerosis in Eastern Iran |
| Q37743241 | Axo-glial antigens as targets in multiple sclerosis: implications for axonal and grey matter injury. |
| Q55092027 | BDNF Polymorphism: A Review of Its Diagnostic and Clinical Relevance in Neurodegenerative Disorders. |
| Q28303860 | Body fluid biomarkers in multiple sclerosis |
| Q38020955 | Bridging the gap from genetic association to functional understanding: the next generation of mouse models of multiple sclerosis |
| Q39824299 | Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies. |
| Q92531242 | Butyrate suppresses demyelination and enhances remyelination |
| Q35255238 | CD40 polymorphisms in Han Chinese patients with Fuch uveitis syndrome. |
| Q33633981 | CD40: novel association with Crohn's disease and replication in multiple sclerosis susceptibility |
| Q35127359 | CD58 polymorphisms associated with the risk of neuromyelitis optica in a Korean population |
| Q33832877 | CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis |
| Q92314703 | CRISPR/Cas9 Screens Reveal Multiple Layers of B cell CD40 Regulation |
| Q41136886 | Chronic progressive multiple sclerosis - pathogenesis of neurodegeneration and therapeutic strategies |
| Q36974852 | Cistromic and genetic evidence that the vitamin D receptor mediates susceptibility to latitude-dependent autoimmune diseases. |
| Q36920509 | Class II HLA interactions modulate genetic risk for multiple sclerosis |
| Q35962257 | Common and Low Frequency Variants in MERTK Are Independently Associated with Multiple Sclerosis Susceptibility with Discordant Association Dependent upon HLA-DRB1*15:01 Status. |
| Q35030410 | Common viruses associated with lower pediatric multiple sclerosis risk |
| Q33840267 | Comparing genotyping algorithms for Illumina's Infinium whole-genome SNP BeadChips |
| Q33630669 | Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci |
| Q24628891 | Confirmation of association between multiple sclerosis and CYP27B1 |
| Q34539647 | Contribution of a common variant in the promoter of the 1-α-hydroxylase gene (CYP27B1) to fracture risk in the elderly |
| Q34963504 | Contribution of genome-wide association studies to scientific research: a pragmatic approach to evaluate their impact |
| Q36638670 | Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis |
| Q55401408 | DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis. |
| Q38167389 | Decoding multiple sclerosis: an update on genomics and future directions |
| Q34580224 | Differential TRAF3 utilization by a variant human CD40 receptor with enhanced signaling |
| Q36848315 | Does environmental confounding mask pleiotropic effects of a multiple sclerosis susceptibility variant on vitamin D in psychosis? |
| Q30569037 | Effectiveness of a web-based protocol for the screening and phenotyping of individuals with Tourette syndrome for genetic studies |
| Q27006548 | Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms |
| Q26823288 | Epigenetics: the missing link to understanding β-cell dysfunction in the pathogenesis of type 2 diabetes |
| Q27010680 | Epistasis and immunity: the role of genetic interactions in autoimmune diseases |
| Q36560009 | Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer's disease, multiple sclerosis and endometriosis |
| Q34184766 | Evidence for CRHR1 in multiple sclerosis using supervised machine learning and meta-analysis in 12,566 individuals |
| Q33772946 | Evidence for polygenic susceptibility to multiple sclerosis--the shape of things to come |
| Q64079297 | Evidence from genome wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibility |
| Q64064448 | Exonic variants of genes related to the vitamin D signaling pathway in the families of familial multiple sclerosis using whole-exome next generation sequencing |
| Q21090198 | Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects |
| Q42645680 | Follow-up study of the first genome-wide association scan in alopecia areata: IL13 and KIAA0350 as susceptibility loci supported with genome-wide significance |
| Q38084534 | From Identification to Characterization of the Multiple Sclerosis Susceptibility Gene CLEC16A. |
| Q42318115 | Functional genomics analysis of vitamin D effects on CD4+ T cells in vivo in experimental autoimmune encephalomyelitis . |
| Q85765348 | Functional relevance for multiple sclerosis-associated genetic variants |
| Q36053844 | GWAS signals across the HLA regions: revealing a clue for common etiology underlying infectious tumors and other immunity diseases |
| Q34040802 | Gender differences in autoimmune disease |
| Q34500740 | Gene Expression Changes in Multiple Sclerosis Relapse Suggest Activation of T and Non-T Cells |
| Q36653406 | Genes and Environment in Multiple Sclerosis project: A platform to investigate multiple sclerosis risk |
| Q37801937 | Genes associated with multiple sclerosis: 15 and counting |
| Q35669464 | Genetic association and altered gene expression of mir-155 in multiple sclerosis patients |
| Q34659651 | Genetic association of rs1520333 G/A polymorphism in the IL7 gene with multiple sclerosis susceptibility in Isfahan population |
| Q33916650 | Genetic burden in multiple sclerosis families |
| Q35915818 | Genetic determinants of risk and progression in multiple sclerosis |
| Q40050869 | Genetic loci for Epstein-Barr virus nuclear antigen-1 are associated with risk of multiple sclerosis |
| Q38387302 | Genetic polymorphisms related to vitamin D and the therapeutic potential of vitamin D in multiple sclerosis |
| Q37101431 | Genetic predictors of 25-hydroxyvitamin D levels and risk of multiple sclerosis |
| Q24635370 | Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis |
| Q37163271 | Genetic risk variants in African Americans with multiple sclerosis |
| Q46000774 | Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits. |
| Q34171280 | Genetic susceptibility to autoimmune thyroid disease: past, present, and future |
| Q42153005 | Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B. |
| Q33790356 | Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility |
| Q28943414 | Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis |
| Q36218526 | Genetically driven target tissue overexpression of CD40: a novel mechanism in autoimmune disease. |
| Q50026932 | Genetics of Multiple Sclerosis: An Overview and New Directions |
| Q37358260 | Genetics of rheumatoid arthritis: GWAS and beyond. |
| Q57623507 | Genetisches Profil der Multiplen Sklerose: Risikogene und die „dunkle Materie“ |
| Q64264939 | Genome-Wide Multiple Sclerosis Association Data and Coagulation |
| Q35384578 | Genome-wide CTCF distribution in vertebrates defines equivalent sites that aid the identification of disease-associated genes. |
| Q28943447 | Genome-wide association analyses identify three new susceptibility loci for primary angle closure glaucoma |
| Q34658391 | Genome-wide association studies in neurology |
| Q54964594 | Genome-wide association studies of multiple sclerosis. |
| Q29417017 | Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease |
| Q33645905 | Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene |
| Q29417047 | Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci |
| Q51415619 | Genomic Effects of the Vitamin D Receptor: Potentially the Link between Vitamin D, Immune Cells, and Multiple Sclerosis. |
| Q43467837 | HLA variants rs9271366 and rs9275328 are associated with systemic lupus erythematosus susceptibility in Malays and Chinese |
| Q54416824 | HLA-DRB1*1501 intensifies the impact of IL-6 promoter polymorphism on the susceptibility to multiple sclerosis in an Iranian population. |
| Q28608339 | Haplotype-based approach to known MS-associated regions increases the amount of explained risk |
| Q41295973 | Heterogeneity in multiple sclerosis: scratching the surface of a complex disease. |
| Q37231684 | High-density genotyping study identifies four new susceptibility loci for atopic dermatitis |
| Q50041799 | Highly conserved extended haplotypes of the major histocompatibility complex and their relationship to multiple sclerosis susceptibility |
| Q47115378 | Histamine Receptor 3 negatively regulates oligodendrocyte differentiation and remyelination. |
| Q34107976 | How to deal with the early GWAS data when imputing and combining different arrays is necessary |
| Q30981879 | Human CLEC16A regulates autophagy through modulating mTOR activity |
| Q36825016 | IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci |
| Q33998401 | IL7Rα contributes to experimental autoimmune encephalomyelitis through altered T cell responses and nonhematopoietic cell lineages |
| Q36512447 | Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis |
| Q34612307 | Identification of shared genes and pathways: a comparative study of multiple sclerosis susceptibility, severity and response to interferon beta treatment |
| Q34331816 | Identity-by-descent mapping to detect rare variants conferring susceptibility to multiple sclerosis |
| Q38682352 | Illuminating vitamin D effects on B cells--the multiple sclerosis perspective |
| Q38686389 | Illuminating vitamin D effects on B-cells - the multiple sclerosis perspective |
| Q28733365 | Immune Regulation of Antibody Access to Neuronal Tissues |
| Q37481373 | Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemia. |
| Q33588039 | Inferring linkage disequilibrium from non-random samples |
| Q37877927 | Insight from genome-wide association studies in rheumatoid arthritis and multiple sclerosis |
| Q34083878 | Interleukin 2 receptor α gene polymorphism and risk of multiple sclerosis: a meta-analysis |
| Q36246917 | Interleukin-2 receptor-α proximal promoter hypomethylation is associated with multiple sclerosis |
| Q36396628 | Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis |
| Q60951031 | Interpreting Non-coding Genetic Variation in Multiple Sclerosis Genome-Wide Associated Regions |
| Q35155990 | Interrogating the complex role of chromosome 16p13.13 in multiple sclerosis susceptibility: independent genetic signals in the CIITA-CLEC16A-SOCS1 gene complex |
| Q34990640 | Intracellular CD24 disrupts the ARF-NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation |
| Q33781868 | KRLMM: an adaptive genotype calling method for common and low frequency variants |
| Q34088851 | Kinase mutations in human disease: interpreting genotype-phenotype relationships |
| Q42748601 | Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis |
| Q36089373 | Layered genetic control of DNA methylation and gene expression: a locus of multiple sclerosis in healthy individuals |
| Q89007011 | Linkage analysis and whole exome sequencing identify a novel candidate gene in a Dutch multiple sclerosis family |
| Q53316377 | Linkage analysis of autopsy-confirmed familial Alzheimer disease supports an Alzheimer disease locus in 8q24. |
| Q27014858 | Linking vitamin d deficiency to inflammatory bowel disease |
| Q64120218 | Long noncoding RNA Malat1 regulates differential activation of macrophages and response to lung injury |
| Q38652893 | Low-Frequency Synonymous Coding Variation in CYP2R1 Has Large Effects on Vitamin D Levels and Risk of Multiple Sclerosis |
| Q57815152 | Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk |
| Q90024827 | MAPK pathway and B cells overactivation in multiple sclerosis revealed by phosphoproteomics and genomic analysis |
| Q86557423 | MS risk allele rs1883832T is associated with decreased mRNA expression of CD40 |
| Q36084601 | Mapping Variation in Cellular and Transcriptional Response to 1,25-Dihydroxyvitamin D3 in Peripheral Blood Mononuclear Cells |
| Q34709339 | Measuring missing heritability: inferring the contribution of common variants |
| Q29617977 | Mechanisms underlying inflammation in neurodegeneration |
| Q60896400 | Members 6B and 14 of the TNF receptor superfamily in multiple sclerosis predisposition |
| Q53077643 | Meta-analysis of TYK2 gene polymorphisms association with susceptibility to autoimmune and inflammatory diseases. |
| Q40762816 | Meta-analysis of associations between MTHFR and GST polymorphisms and susceptibility to multiple sclerosis |
| Q39030292 | Metabolites: deciphering the molecular language between DCs and their environment. |
| Q21562182 | MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood |
| Q33796163 | Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data |
| Q39129087 | Modulating effects of WT1 on interferon-β-vitamin D association in MS. |
| Q33954440 | Multiple loci are associated with white blood cell phenotypes |
| Q83785437 | Multiple sclerosis |
| Q37742105 | Multiple sclerosis etiology: beyond genes and environment |
| Q87928799 | Multiple sclerosis genetics |
| Q37772077 | Multiple sclerosis genetics--is the glass half full, or half empty? |
| Q43788381 | Multiple sclerosis in New Zealand Māori |
| Q36594174 | Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls |
| Q28732826 | Multiple sclerosis risk variant HLA-DRB1*1501 associates with high expression of DRB1 gene in different human populations |
| Q47844741 | Multiple sclerosis risk variants alter expression of co-stimulatory genes in B cells |
| Q33892035 | Multiple sclerosis susceptibility alleles in African Americans. |
| Q35018274 | Multiple sclerosis susceptibility genes: associations with relapse severity and recovery |
| Q30980357 | Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients |
| Q33899907 | Multiple sclerosis, vitamin D, and HLA-DRB1*15. |
| Q43138599 | Multiple sclerosis: from molecules to treatment |
| Q38801813 | Multiple sclerosis: genetics, biomarkers, treatments |
| Q30639610 | Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls |
| Q92425137 | Next-generation sequencing identifies contribution of both class I and II HLA genes on susceptibility of multiple sclerosis in Japanese |
| Q37331388 | Next-generation sequencing in understanding complex neurological disease |
| Q35187912 | No association between identified multiple sclerosis non-MHC risk loci and neuromyelitis optica |
| Q36780814 | No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis |
| Q43805147 | Novel modulating effects of PKC family genes on the relationship between serum vitamin D and relapse in multiple sclerosis. |
| Q37670027 | Opportunities for Translation from the Bench: Therapeutic Intervention of the JAK/STAT Pathway in Neuroinflammatory Diseases. |
| Q34098864 | Perspectives on the use of multiple sclerosis risk genes for prediction |
| Q52615322 | PheWAS and Beyond: The Landscape of Associations with Medical Diagnoses and Clinical Measures across 38,662 Individuals from Geisinger. |
| Q90263726 | Pleiotropic Roles of P2X7 in the Central Nervous System |
| Q36189767 | PoCos: Population Covering Locus Sets for Risk Assessment in Complex Diseases |
| Q84379286 | Polymorphic locus rs10492972 of the KIF1B gene association with multiple sclerosis in Russia: case control study |
| Q34567623 | Polymorphism of the IL-18 and CD40 genes and Liver Transplant Outcome in Iranian Patients |
| Q28742974 | Polymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibility |
| Q36154012 | Profile of differential promoter activity by nucleotide substitution at GWAS signals for multiple sclerosis |
| Q36382352 | Progress in multiple sclerosis genetics |
| Q34456223 | Protein-protein interaction analysis highlights additional loci of interest for multiple sclerosis |
| Q36043340 | Psoriasis and other complex trait dermatoses: from Loci to functional pathways |
| Q57224463 | RGMA and IL21R show association with experimental inflammation and multiple sclerosis |
| Q38140023 | Recent progress in omics-driven analysis of MS to unravel pathological mechanisms |
| Q33980298 | Refining the association of MHC with multiple sclerosis in African Americans |
| Q35008221 | Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis |
| Q44822764 | Replication of top markers of a genome-wide association study in multiple sclerosis in Spain. |
| Q58547359 | Replication study of GWAS risk loci in Greek multiple sclerosis patients |
| Q89820980 | Replication study of susceptibility variants associated with allergic rhinitis and allergy in Han Chinese |
| Q57309064 | Reply to “Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis” |
| Q39900185 | Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study |
| Q22252206 | Revealing the genetic basis of multiple sclerosis: are we there yet? |
| Q37832644 | Revisiting the T-cell receptor alpha/delta locus and possible associations with multiple sclerosis. |
| Q37857943 | Risk conferring genes in multiple sclerosis |
| Q38936794 | Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study. |
| Q30514239 | SNP-based analysis of the HLA locus in Japanese multiple sclerosis patients |
| Q37351905 | Shared Genetic Etiology of Autoimmune Diseases in Patients from a Biorepository Linked to De-identified Electronic Health Records |
| Q37852786 | Shared genetics in coeliac disease and other immune-mediated diseases |
| Q35146487 | Single nucleotide polymorphism (SNP)-strings: an alternative method for assessing genetic associations |
| Q37990779 | Single nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers. |
| Q36225257 | Single-nucleotide polymorphism at CYP27B1-1260, but not VDR Taq I, is possibly associated with persistent hepatitis B virus infection |
| Q39127014 | Stimulated PBMC-produced IFN-γ and TNF-α are associated with altered relapse risk in multiple sclerosis: results from a prospective cohort study |
| Q34482096 | Study of association of CD40-CD154 gene polymorphisms with disease susceptibility and cardiovascular risk in Spanish rheumatoid arthritis patients. |
| Q41189386 | Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array |
| Q34491571 | Susceptibility Genes for Multiple Sclerosis Identified in a Gene-Based Genome-Wide Association Study |
| Q28744024 | Systematic review of genome-wide expression studies in multiple sclerosis |
| Q35821666 | TNF superfamily in inflammatory disease: translating basic insights |
| Q34329229 | Tag-SNP analysis of the GFI1-EVI5-RPL5-FAM69 risk locus for multiple sclerosis |
| Q36016728 | The Association Between Genetic Polymorphism rs703842 in CYP27B1 and Multiple Sclerosis: A Meta-Analysis |
| Q54697963 | The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cells. |
| Q27013381 | The Evi5 family in cellular physiology and pathology |
| Q28067131 | The Gas6/TAM System and Multiple Sclerosis |
| Q47133073 | The Gateway Reflex, a Novel Neuro-Immune Interaction for the Regulation of Regional Vessels |
| Q45949302 | The Genetics of Multiple Sclerosis: From 0 to 200 in 50 Years. |
| Q35661793 | The MS Risk Allele of CD40 Is Associated with Reduced Cell-Membrane Bound Expression in Antigen Presenting Cells: Implications for Gene Function |
| Q42662127 | The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis |
| Q33559946 | The effect of single nucleotide polymorphisms from genome wide association studies in multiple sclerosis on gene expression |
| Q24623195 | The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings |
| Q37993033 | The evidence for a role of B cells in multiple sclerosis |
| Q21560832 | The genetic association of variants in CD6, TNFRSF1A and IRF8 to multiple sclerosis: a multicenter case-control study |
| Q38020959 | The genetics of multiple sclerosis: an up-to-date review |
| Q26825782 | The genetics of multiple sclerosis: review of current and emerging candidates |
| Q33799335 | The human health effects of ozone depletion and interactions with climate change. |
| Q37943296 | The major cause of multiple sclerosis is environmental: genetics has a minor role--yes |
| Q50155916 | The multiple sclerosis risk allele within the AHI1 gene is associated with relapses in children and adults |
| Q57667575 | The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis |
| Q53317129 | The multiple sclerosis-associated regulatory variant rs10877013 affects expression of CYP27B1 and VDR under inflammatory or vitamin D stimuli. |
| Q38376270 | The role of epidemiology in MS research: Past successes, current challenges and future potential |
| Q38198086 | Therapeutic potential of tyrosine kinase 2 in autoimmunity. |
| Q90754646 | Tolerance regeneration by T regulatory cells in autologous haematopoietic stem cell transplantation for autoimmune diseases |
| Q26775820 | Translational utility of experimental autoimmune encephalomyelitis: recent developments |
| Q37729042 | Update on the genetic risk factors for rheumatoid arthritis |
| Q39140582 | VDBP, CYP27B1, and 25-Hydroxyvitamin D Gene Polymorphism Analyses in a Group of Sicilian Multiple Sclerosis Patients. |
| Q45372857 | Validation of IRF5 as multiple sclerosis risk gene: putative role in interferon beta therapy and human herpes virus-6 infection. |
| Q33683237 | Variants in the IL7RA gene confer susceptibility to multiple sclerosis in Caucasians: evidence based on 9734 cases and 10436 controls |
| Q35674960 | Variants of Interferon Regulatory Factor 5 are Associated with Neither Neuromyelitis Optica Nor Multiple Sclerosis in the Southeastern Han Chinese Population |
| Q28943396 | Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis |
| Q37961446 | Viruses and vitamin D in the etiology of type 1 diabetes mellitus and multiple sclerosis |
| Q54073705 | Vitamin D and multiple sclerosis |
| Q57038551 | Vitamin D for the treatment of multiple sclerosis: a meta-analysis |
| Q36122415 | Vitamin D receptor binding, chromatin states and association with multiple sclerosis. |
| Q45363896 | Vitamin D: a link between Epstein-Barr virus and multiple sclerosis development? |
| Q37721243 | Vitamin-D Deficiency As a Potential Environmental Risk Factor in Multiple Sclerosis, Schizophrenia, and Autism |
| Q33695782 | What role for genetics in the prediction of multiple sclerosis? |
| Q35956144 | XVI European Charcot Foundation lecture: nutrition and environment: can MS be prevented? |
| Q52886444 | [Vitamin D and multiple sclerosis : the role for risk of disease and treatment]. |
Search more.